Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, ...

First Patient Expected to be Dosed Next Week with Intranasal ForalumabPET Scan Shows Presence of Untreated Neuroinflammation ...

We lift the bonnet on a foundational piece of synth genius, and demonstrate how you can achieve its distinctive sound ...

Formation Bio has acquired the global rights, excluding in Greater China, to LNK01006 from Lynk Pharmaceuticals.

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Direct-fed Microbials (DFM) Market Surges to USD 6.2 Billion by 2033, Propelled by 7.0% CAGR - Verified Market Reports (R) ...

Alternanthera littoralis, commonly called Joseph’s Coat, is native to Brazil’s coastal regions and has a long history of use ...

D network architecture and the backbone of 6G NTNs. Opportunities and challenges with NTNs. Non-terrestrial networks (NTNs) ...

The data center network has reached a critical point. As companies race to build massive XPU clusters for AI, traditional ...